156 related articles for article (PubMed ID: 37185612)
1. Histological markers, sickle-shaped blood vessels, myxoid area, and infiltrating growth pattern help stratify the prognosis of patients with myxofibrosarcoma/undifferentiated sarcoma.
Washimi K; Kasajima R; Shimizu E; Sato S; Okubo Y; Yoshioka E; Narimatsu H; Hiruma T; Katayama K; Yamaguchi R; Yamaguchi K; Furukawa Y; Miyano S; Imoto S; Yokose T; Miyagi Y
Sci Rep; 2023 Apr; 13(1):6744. PubMed ID: 37185612
[TBL] [Abstract][Full Text] [Related]
2. Management of Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma.
Crago AM; Cardona K; Koseła-Paterczyk H; Rutkowski P
Surg Oncol Clin N Am; 2022 Jul; 31(3):419-430. PubMed ID: 35715142
[TBL] [Abstract][Full Text] [Related]
3. Impact of infiltrative growth on the outcome of patients with undifferentiated pleomorphic sarcoma and myxofibrosarcoma.
Iwata S; Yonemoto T; Araki A; Ikebe D; Kamoda H; Hagiwara Y; Ishii T
J Surg Oncol; 2014 Nov; 110(6):707-11. PubMed ID: 24975462
[TBL] [Abstract][Full Text] [Related]
4. Comparative Study of Myxofibrosarcoma With Undifferentiated Pleomorphic Sarcoma: Histopathologic and Clinicopathologic Review.
Yoshimoto M; Yamada Y; Ishihara S; Kohashi K; Toda Y; Ito Y; Yamamoto H; Furue M; Nakashima Y; Oda Y
Am J Surg Pathol; 2020 Jan; 44(1):87-97. PubMed ID: 31651522
[TBL] [Abstract][Full Text] [Related]
5. The association between tumour progression and vascularity in myxofibrosarcoma and myxoid/round cell liposarcoma.
Mentzel T; Brown LF; Dvorak HF; Kuhnen C; Stiller KJ; Katenkamp D; Fletcher CD
Virchows Arch; 2001 Jan; 438(1):13-22. PubMed ID: 11213831
[TBL] [Abstract][Full Text] [Related]
6. Epithelioid variant of myxofibrosarcoma: expanding the clinicomorphologic spectrum of myxofibrosarcoma in a series of 17 cases.
Nascimento AF; Bertoni F; Fletcher CD
Am J Surg Pathol; 2007 Jan; 31(1):99-105. PubMed ID: 17197925
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin protease expression in infiltrative soft tissue sarcomas: cathepsin-K correlates with infiltrative tumor growth and clinical outcomes.
Fujiwara T; Zhang L; Chandler A; Sung S; Yakoub M; Linkov I; Hameed M; Healey JH
Hum Pathol; 2023 Apr; 134():30-44. PubMed ID: 36565726
[TBL] [Abstract][Full Text] [Related]
8. Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma.
Nakayama R; Nemoto T; Takahashi H; Ohta T; Kawai A; Seki K; Yoshida T; Toyama Y; Ichikawa H; Hasegawa T
Mod Pathol; 2007 Jul; 20(7):749-59. PubMed ID: 17464315
[TBL] [Abstract][Full Text] [Related]
9. GLUT-1 expression is helpful to distinguish myxofibrosarcoma from nodular fasciitis.
Nakayama S; Nishio J; Aoki M; Koga K; Nabeshima K; Yamamoto T
Histol Histopathol; 2023 Jan; 38(1):47-51. PubMed ID: 35792526
[TBL] [Abstract][Full Text] [Related]
10. Unveiling the Genomic Basis of Chemosensitivity in Sarcomas of the Extremities: An Integrated Approach for an Unmet Clinical Need.
Vanni S; Fausti V; Fonzi E; Liverani C; Miserocchi G; Spadazzi C; Cocchi C; Calabrese C; Gurrieri L; Riva N; Recine F; Casadei R; Pieri F; Guerrieri AN; Serra M; Ibrahim T; Mercatali L; De Vita A
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108089
[TBL] [Abstract][Full Text] [Related]
11. [Low malignancy myxofibrosarcoma versus low malignancy fibromyxoid sarcoma. Distinct entities with similar names but different clinical course].
Mentzel T; Katenkamp D; Fletcher CD
Pathologe; 1996 Mar; 17(2):116-21. PubMed ID: 8650138
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance and functional significance of cell-free microRNA-1260b expression profiles in infiltrative myxofibrosarcoma.
Morita T; Fujiwara T; Yoshida A; Uotani K; Kiyono M; Yokoo S; Hasei J; Kunisada T; Ozaki T
Sci Rep; 2020 Jun; 10(1):9414. PubMed ID: 32523124
[TBL] [Abstract][Full Text] [Related]
13. Low-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems.
Huang HY; Lal P; Qin J; Brennan MF; Antonescu CR
Hum Pathol; 2004 May; 35(5):612-21. PubMed ID: 15138937
[TBL] [Abstract][Full Text] [Related]
14. Cytopathology of myxofibrosarcoma: a study of 66 cases and literature review.
Wakely PE
J Am Soc Cytopathol; 2021; 10(3):300-309. PubMed ID: 33041221
[TBL] [Abstract][Full Text] [Related]
15. Fine-needle aspiration in myxofibrosarcoma: experience of Institut Curie.
Colin P; Lagacé R; Caillaud JM; Sastre-Garau X; Klijanienko J
Diagn Cytopathol; 2010 May; 38(5):343-6. PubMed ID: 19899126
[TBL] [Abstract][Full Text] [Related]
16. Systematic screening identifies a 2-gene signature as a high-potential prognostic marker of undifferentiated pleomorphic sarcoma/myxofibrosarcoma.
Hu Q; Zhou S; Hu X; Zhang H; Huang S; Wang Y
J Cell Mol Med; 2020 Jan; 24(1):1010-1021. PubMed ID: 31742892
[TBL] [Abstract][Full Text] [Related]
17. Does pre-operative MRI predict the risk of local recurrence in primary myxofibrosarcoma of the extremities?
Sambri A; Spinnato P; Bazzocchi A; Tuzzato GM; Donati D; Bianchi G
Asia Pac J Clin Oncol; 2019 Oct; 15(5):e181-e186. PubMed ID: 31111597
[TBL] [Abstract][Full Text] [Related]
18. Rb and p53-Deficient Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma Require Skp2 for Survival.
Li GZ; Okada T; Kim YM; Agaram NP; Sanchez-Vega F; Shen Y; Tsubokawa N; Rios J; Martin AS; Dickson MA; Qin LX; Socci ND; Singer S
Cancer Res; 2020 Jun; 80(12):2461-2471. PubMed ID: 32161142
[TBL] [Abstract][Full Text] [Related]
19. MRI Features as Prognostic Factors in Myxofibrosarcoma: Proposal of MRI Grading System.
Spinnato P; Clinca R; Vara G; Cesari M; Ponti F; Facchini G; Longhi A; Donati DM; Bianchi G; Sambri A
Acad Radiol; 2021 Nov; 28(11):1524-1529. PubMed ID: 32928636
[TBL] [Abstract][Full Text] [Related]
20. Claudin 6 expression is useful to distinguish myxofibrosarcomas from other myxoid soft tissue tumors.
Bekki H; Yamamoto H; Takizawa K; Iwasaki T; Otsuka H; Yamada Y; Kohashi K; Harimaya K; Iwamoto Y; Oda Y
Pathol Res Pract; 2017 Jun; 213(6):674-679. PubMed ID: 28476380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
